Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis.

Soichiro KakimotoMorikazu MiyamotoTakahiro EinamaYasuhiro TakihataHiroko MatsuuraHideki IwahashiHiroki IshibashiTakahiro SakamotoTaira HadaJin SuminokuraTsubasa ItoRie SuzukiAyako SuzukiMasashi Takano

Published in: Diagnostic pathology (2021)

Mesothelin expression and co-expression might be associated with tumor aggressiveness and poor prognosis in patients with endometrial carcinoma. Persons with mesothelin-expressing endometrial cancers present a particularly high medical unmet need.

Keyphrases

poor prognosis
long non coding rna
endometrial cancer
healthcare
binding protein